Collapsing Glomerulopathy.
APOL1
Collapsing glomerulopathy
Focal segmental glomerulosclerosis
Interferon
Nephrotic syndrome
Podocyte
Journal
Advances in kidney disease and health
ISSN: 2949-8139
Titre abrégé: Adv Kidney Dis Health
Pays: United States
ID NLM: 9918523075306676
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
26
06
2023
revised:
08
03
2024
accepted:
25
03
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
ppublish
Résumé
Collapsing glomerulopathy (CG) is a pattern of kidney injury characterized by segmental or global collapse of the glomerular tuft associated with overlying epithelial cell hyperplasia. Although CG may be idiopathic, a wide range of etiologies have been identified that can lead to this pattern of injury. Recent advances have highlighted the role of inflammatory and interferon signaling pathways and upregulation of apolipoprotein L1 (APOL1) within podocytes in those carrying a high-risk APOL1 genotype. In this review, we describe the etiology, pathogenesis, pathology, and clinical course of CG, focusing on nonviral etiologies. We also describe current treatments and explore potential therapeutic options targeting interferon/APOL1 pathways in CG.
Identifiants
pubmed: 39084754
pii: S2949-8139(24)00058-2
doi: 10.1053/j.akdh.2024.03.008
pii:
doi:
Substances chimiques
Apolipoprotein L1
0
APOL1 protein, human
0
Apolipoproteins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
290-298Informations de copyright
Copyright © 2024 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.